Format

Send to

Choose Destination
J Ophthalmic Vis Res. 2012 Apr;7(2):130-3.

Oral propranolol for treatment of pediatric capillary hemangiomas.

Author information

1
Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abstract

PURPOSE:

To report the long-term results of treatment of pediatric capillary hemangiomas with oral propranolol.

METHODS:

Three infants, 3 to 4 months of age, with periocular capillary hemangiomas were treated with oral propranolol solution (Inderal, 20mg/5ml) 2-3 mg/kg per day divided in 2 doses. Propranolol was continued up to the end of the first year of life and tapered over 2-3 weeks. All infants were followed for 20 months. Lesion size and evolution were assessed during the follow-up period.

RESULTS:

Significant improvement was noted in all patients in the first 2 months of therapy with slow and continuous effect throughout the follow-up period. No serious complications were observed.

CONCLUSION:

Oral propranolol can be used as a first line agent in children with capillary hemangiomas.

KEYWORDS:

Capillary Hemangioma; Oral Propranolol

PMID:
23275821
PMCID:
PMC3520472

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center